SCY-575

N/A

Report date: 2022/01/25 17:54:53
NME

Base Information

Drug NameSCY-575
Drug Alias NameCyclophilin D inhibitors - SCYNEXISSCY-575SCY-641
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin A inhibitors
TargetsCyclophilin A
Therapy Area/IndicationsNerve DegenerationIschemiaInflammation +[11
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScynexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNerve DegenerationIschemiaInflammation +[11

Other Information

ATC CodeN/A
Related LinksN/A